Perception, knowledge, and handling practice regarding the risk of exposure to antineoplastic drugs in oncology day hospitalization units and compounding unit staff.

Occupational exposure antineoplastic perception healthcare worker practice healthcare worker antineoplastic

Journal

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
ISSN: 1477-092X
Titre abrégé: J Oncol Pharm Pract
Pays: England
ID NLM: 9511372

Informations de publication

Date de publication:
29 May 2022
Historique:
entrez: 31 5 2022
pubmed: 1 6 2022
medline: 1 6 2022
Statut: aheadofprint

Résumé

Antineoplastic drug exposure is a major problem in regard to caregivers' health. The aim of the present study was to assess the perception, knowledge, and handling practices of all occupation level categories of two oncology day hospitalization units and two compounding units regarding the risk of exposure to antineoplastic drugs. This descriptive study, performed through face-to-face interviews, concurrently assessed the perception, knowledge, and handling practices of antineoplastic drugs in five different job categories in four different settings. This work was part of a larger comprehensive project examining surface and blood contamination. Different scores were assigned to evaluate responses to a questionnaire about the perception, knowledge, and handling practices of healthcare workers, a risk global score including a risk perception score, and education/knowledge and handling practices scores. In the survey, continuous training was associated with the global risk score ( This study identified significant differences among healthcare workers depending on job categories in the antineoplastic drug handling practices and in the knowledge of the risks associated with occupational exposure to antineoplastic drugs. These differences were particularly important between trained and untrained participants, revealing the importance of implementing a continuous training program.

Sections du résumé

BACKGROUND BACKGROUND
Antineoplastic drug exposure is a major problem in regard to caregivers' health. The aim of the present study was to assess the perception, knowledge, and handling practices of all occupation level categories of two oncology day hospitalization units and two compounding units regarding the risk of exposure to antineoplastic drugs.
METHODS METHODS
This descriptive study, performed through face-to-face interviews, concurrently assessed the perception, knowledge, and handling practices of antineoplastic drugs in five different job categories in four different settings. This work was part of a larger comprehensive project examining surface and blood contamination. Different scores were assigned to evaluate responses to a questionnaire about the perception, knowledge, and handling practices of healthcare workers, a risk global score including a risk perception score, and education/knowledge and handling practices scores.
RESULTS RESULTS
In the survey, continuous training was associated with the global risk score (
CONCLUSIONS CONCLUSIONS
This study identified significant differences among healthcare workers depending on job categories in the antineoplastic drug handling practices and in the knowledge of the risks associated with occupational exposure to antineoplastic drugs. These differences were particularly important between trained and untrained participants, revealing the importance of implementing a continuous training program.

Identifiants

pubmed: 35635230
doi: 10.1177/10781552221103803
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10781552221103803

Auteurs

Hubert Benoist (H)

357634Normandie Univ., ABTE, centre de lutte contre le cancer François Baclesse, Caen, France.
Service de pharmacie, 26962centre hospitalier universitaire de Caen, Caen, France.

Amandine Busson (A)

Institut National de la Santé et de la Recherche Médicale (INSERM), Unité Mixte de Recherche (UMR) 1086 ANTICIPE, Caen, France.
Université de Caen Normandie, Caen, France.
Centre de lutte contre le cancer François Baclesse, Caen, France.

Audrey Faveyrial (A)

Service d'hospitalisation de jour de cancérologie, centre de lutte contre le cancer François Baclesse, Caen, France.

Karine Bouhier-Leporrier (K)

Service d'hospitalisation de jour de gastro-entérologie, centre hospitalier universitaire de Caen, Caen, France.

Fabienne Divanon (F)

Service de pharmacie, 55072centre de lutte contre le cancer François Baclesse, Caen, France.

Cécile Breuil (C)

Service de pharmacie, 26962centre hospitalier universitaire de Caen, Caen, France.

Sophie Roger-Leenaert (S)

Service de médecine du travail, centre hospitalier universitaire de Caen, Caen, France.

Agnès Palix (A)

Service de médecine du travail, centre de lutte contre le cancer François Baclesse, Caen, France.

Pascal Odou (P)

27023Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France.

Nicolas Simon (N)

27023Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France.

Guillaume Saint-Lorant (G)

357634Normandie Univ., ABTE, centre de lutte contre le cancer François Baclesse, Caen, France.
Service de pharmacie, 26962centre hospitalier universitaire de Caen, Caen, France.

Classifications MeSH